Efficacy of metabolic surgery on hba1c decrease in type 2 diabetes mellitus patients with BMI <35 kg/m2 - A review

Obesity Surgery

Volumn 24, Issue 1, 2014, Pages 148-158

  Ngiam, Kee Yuan ^a   Lee, Wei Jei ^b   Lee, Yi Chih ^c   Cheng, Anton ^a  

^a KHOO TECK PUAT HOSPITAL   (Singapore)

^b MIN SHENG GENERAL HOSPITAL   (Taiwan)

^c CHING YUN UNIVERSITY   (Taiwan)

Author keywords

Biliopancreatic bypass; Body mass index <35 kg m2; Diabetes remission; Diabetes surgery; Gastric bypass; HbA1c; Metabolic surgery; Mini gastric bypass; Non morbidly obese; Non obese; Roux en Y; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

ADJUSTABLE GASTRIC BANDING; ANASTOMOSIS LEAKAGE; ARTICLE; BILIOPANCREATIC BYPASS; BODY MASS; DIABETIC PATIENT; DUODENAL JEJUNAL BYPASS; EROSION; GASTRIC BANDING; GASTROINTESTINAL SURGERY; HEMOGLOBIN BLOOD LEVEL; HERNIA; HUMAN; ILEAL INTERPOSITION WITH SLEEVE GASTRECTOMY; INTERNAL HERNIATION; INTESTINE OBSTRUCTION; LAPAROSCOPIC SLEEVE GASTRECTOMY; METABOLIC SURGERY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SLEEVE GASTRECTOMY; STOMACH BYPASS; VENTRAL HERNIATION; VOMITING;

BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; TREATMENT OUTCOME;

EID: 84893667671     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-1112-y     Document Type: Article

References (76)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-7. Epub 2001/12/14.
2. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129-40. Epub 2009/05/28.
3. Best JH, Lavillotti K, DeYoung MB, et al. The effects of exenatide bid on metabolic control, medication use and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic review. Diabetes Obes Metab. 2012;14(5):387-98. Epub 2011/11/15.
4. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724-37. Epub 2004/10/14.
5. Hamet P. What matters in ADVANCE and ADVANCE-ON. Diabetes Obes Metab. 2012;14 Suppl 1:20-9. Epub 2011/12/14.
6. 2: an integrative review of early studies. Obes Surg. 2010;20(6):776-90. Epub 2010/03/25.
7. 2: a literature review. Diabetes Technol Ther. 2012;14(4):365-72. Epub 2011/12/20.
8. Shimizu H, Timratana P, Schauer PR, et al. Review of metabolic surgery for type 2 diabetes in patients with a BMI<35 kg/m(2). J Obes. 2012;2012:147256. Epub 2012/06/22.
9. 2. Diabetes Obes Metab. 2012;14(3):262-70. Epub 2011/11/05.
10. Diagnosis and classification of diabetes mellitus. Diabetes care. 2010;33 Suppl 1:S62-9. Epub 2010/01/29.
11. Pournaras DJ, Aasheim ET, Sovik TT, et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg. 2012;99(1):100-3. Epub 2011/10/25.
12. DePaula AL, Macedo AL, Rassi N, et al. Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc. 2008;22(12):2670-8. Epub 2008/03/19.
13. Kim JW, Cheong JH, Hyung WJ, et al. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenter: WJG. 2012;18(1):49-54. Epub 2012/01/10.
14. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567-76. Epub 2012/03/28.
15. DePaula AL, Stival A, Halpern A, et al. Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI <35: an analysis of 454 consecutive patients. World J Surg. 2011;35(1):102-8. Epub 2010/11/06.
16. DePaula AL, Stival AR, DePaula CC, et al. Surgical treatment of type 2 diabetes in patients with BMI below 35: mid-term outcomes of the laparoscopic ileal interposition associated with a sleeve gastrectomy in 202 consecutive cases. J Gastrointest Surg: Off J Soc Surg Aliment Tract. 2012;16(5):967-76. Epub 2012/02/22.
17. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care. 2008;31 Suppl 2:S290-6. Epub 2008/02/15.
18. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577-85. Epub 2012/03/28.
19. Dixon JB, Hur KY, Lee WJ, Kim MJ, Chong K, Chen SC, et al. Gastric bypass in type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes. Diabetic medicine: a journal of the British Diabetic Association. 2012. Epub 2013/01/03.
20. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998;316(7134):823-8. Epub 1998/04/29.
21. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800-11. Epub 2010/03/05.
22. Turnbull FM, Abraira C, Anderson RJ, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52(11):2288-98. Epub 2009/08/06.
23. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-12. Epub 2000/08/11.
24. Shah S, Shah P, Todkar J, et al. Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2010;6(2):152-7. Epub 2010/03/02.
25. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143-8. Epub 2011/02/23.
26. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-23. Epub 2008/01/24.
27. O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625-33. Epub 2006/05/04.
28. De Paula AL, Stival AR, Macedo A, et al. Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m(2). Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2010;6(3):296-304. Epub 2010/01/26.
29. 2. Obes Surg. 2007;17(2):185-92. Epub 2007/05/05.
30. Cohen R, Caravatto PP, Correa JL, et al. Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2012;8(4):375-80. Epub 2012/03/14.
31. Lakdawala M, Shaikh S, Bandukwala S, Remedios C, Shah M, Bhasker AG. Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m(2)) Indian patients with type 2 diabetes mellitus. Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery. 2012. Epub 2012/10/17.
32. 2. J Gastrointest Surg: Off J Soc Surg Aliment Tract. 2008;12(5):945-52. Epub 2007/10/18.
33. Kashyap SR, Bhatt DL, Wolski K, Watanabe RM, Abdul-Ghani M, Abood B, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes care. 2013. Epub 2013/02/27.
34. 2. Obes Surg. 2004;14(3):415-8. Epub 2004/04/10.
35. Choi J, Digiorgi M, Milone L, et al. Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2010;6(4):367-71. Epub 2010/02/27.
36. Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg. 2010;252(3):559-66. discussion 66-7. Epub 2010/08/27.
37. 2. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2012;8(1):25-30. Epub 2011/10/25.
38. Lee WJ, Hur KY, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg: Off J Soc Surg Aliment Tract. 2012;16(1):45-51. discussion -2. Epub 2011/11/02.
39. 2. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2006;2(5):518-22. Epub 2006/10/04.
40. 2. Surg Endosc. 2009;23(7):1569-73.
41. 2) compared to severely obese. Obes Surg. 2011;21(4):421-5. Epub 2011/02/11.
42. 2: a report of 2 cases. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2007;3(2):195-7. Epub 2007/03/28.
43. Ferzli GS, Dominique E, Ciaglia M, et al. Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg. 2009;33(5):972-9. Epub 2009/03/17.
44. Geloneze B, Geloneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg. 2009;19(8):1077-83. Epub 2009/05/29.
45. Klein S, Fabbrini E, Patterson BW, et al. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity (Silver Spring). 2012;20(6):1266-72. Epub 2012/01/21.
46. Lee HC, Kim MK, Kwon HS, et al. Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients. Obes Surg. 2010;20(11):1530-5. Epub 2010/08/31.
47. 2 (LBMI). Obes Surg. 2009;19(3):307-12. Epub 2008/11/07.
48. 2: sleeve gastrectomy versus medical treatment. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2012;8(1):20-4. Epub 2011/09/20.
49. 2). Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2009;5(4):425-8. Epub 2008/11/11.
50. Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery. 2010;147(5):664-9. Epub 2009/12/17.
51. Noun R, Chakhtoura G, Nasr M, et al. Laparoscopic sleeve gastrectomy for mildly obese patients (body mass index of 30 <35 kg/m(2)): operative outcome and short-term results. J Obes. 2012;2012:813650. Epub 2013/01/11.
52. 2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB. Obes Facts. 2011;4 Suppl 1:13-7. Epub 2011/11/02.
53. Kasama K, Tagaya N, Kanehira E, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg. 2009;19(10):1341-5. Epub 2009/07/25.
54. Raj PP, Kumaravel R, Chandramaliteeswaran C, et al. Laparoscopic duodenojejunal bypass with sleeve gastrectomy: preliminary results of a prospective series from India. Surg Endosc. 2012;26(3):688-92. Epub 2011/10/14.
55. Goel R, Amin P, Goel M, et al. Early remission of type 2 diabetes mellitus by laparoscopic ileal transposition with sleeve gastrectomy surgery in 23-35 BMI patients. Int J Diabetes Dev Ctries. 2011;31(2):91-6.
56. Kota SK, Ugale S, Gupta N, et al. Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus. Indian J Endocrinol Metab. 2012;16(4):589-98. Epub 2012/07/28.
57. Kumar KV, Ugale S, Gupta N, et al. Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther. 2009;11(12):785-9. Epub 2009/12/17.
58. Tinoco A, El-Kadre L, Aquiar L, et al. Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg. 2011;35(10):2238-44. Epub 2011/07/12.
59. 2. A cohort study. Obes Surg. 2012;22(7):1097-103. Epub 2012/04/25.
60. Boza C, Munoz R, Salinas J, et al. Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients. Obes Surg. 2011;21(9):1330-6. Epub 2011/07/12.
61. Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420-8. Epub 2012/06/23.
62. Cohen R, Pinheiro JS, Correa JL, et al. Laparoscopic Roux-en-Y gastric bypass for BMI<35 kg/m(2): a tailored approach. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2006;2(3):401-4. discussion 4. Epub 2006/08/24.
63. 2. Obes Surg. 2011;21(3):283-7. Epub 2010/12/15.
64. Huang CK, Shabbir A, Lo CH, et al. Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obes Surg. 2011;21(9):1344-9. Epub 2011/04/12.
65. Lanzarini E, Csendes A, Lembach H, et al. Evolution of type 2 diabetes mellitus in non morbid obese gastrectomized patients with Roux en-Y reconstruction: retrospective study. World J Surg. 2010;34(9):2098-102. Epub 2010/06/10.
66. Navarrete SA, Leyba JL, Llopis SN. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for the treatment of type 2 diabetes in non-obese patients: technique and preliminary results. Obes Surg. 2011;21(5):663-7. Epub 2011/02/22.
67. 2. Pol Przegl Chir. 2011;83(2):81-6. Epub 2011/12/15.
68. 2. Surgery. 2011;150(4):684-91. Epub 2011/10/18.
69. Shah SS, Todkar JS, Shah PS, et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2). Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2010;6(4):332-8. Epub 2009/10/23.
70. 2 in type 2 diabetes mellitus. Obes Surg. 2012;22:1562-7.
71. Garcia-Caballero M, Valle M, Martinez-Moreno JM, et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with one anastomosis gastric bypass. Nutr Hosp: Org Off Soc Esp Nutr Parente Enter. 2012;27(2):623-31. Epub 2012/06/27.
72. 2. Obes Surg. 2011;21(7):889-95. Epub 2011/04/19.
73. Kim Z, Hur KY. Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. W J Surg. 2011;35(3):631-6. Epub 2010/12/18.
74. 2. Diabetologia. 2009;52(6):1027-30. Epub 2009/03/25.
75. 2): a prospective controlled study. Obes Surg. 2011;21(7):880-8. Epub 2011/05/05.
76. Noya G, Cossu ML, Coppola M, et al. Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type II: results in the first 10 cases. Obes Surg. 1998;8(1):67-72. Epub 1998/04/30.